The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs

被引:57
|
作者
Ghisays, Fiorella [1 ]
Brace, Cynthia S. [2 ]
Yackly, Shawn M. [1 ]
Kwon, Hyock Joo [1 ]
Mills, Kathryn F. [2 ]
Kashentseva, Elena [3 ]
Dmitriev, Igor P. [3 ]
Curiel, David T. [3 ]
Imai, Shin-ichiro [2 ]
Ellenberger, Tom [1 ]
机构
[1] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA
来源
CELL REPORTS | 2015年 / 10卷 / 10期
关键词
DNA-DAMAGE RESPONSE; ALLOSTERIC ACTIVATORS; NEGATIVE REGULATOR; GLUCOSE; PROTEIN; NAD(+); DBC1; DISEASE; CANCER; MICE;
D O I
10.1016/j.celrep.2015.02.036
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The NAD(+)-dependent protein deacetylase SIRT1 regulates energy metabolism, responses to stress, and aging by deacetylating many different proteins, including histones and transcription factors. The mechanisms controlling SIRT1 enzymatic activity are complex and incompletely characterized, yet essential for understanding how to develop therapeutics that target SIRT1. Here, we demonstrate that the N-terminal domain of SIRT1 (NTERM) can trans-activate deacetylation activity by physically interacting with endogenous SIRT1 and promoting its association with the deacetylation substrate NF-kappa B p65. Two motifs within the NTERM domain contribute to activation of SIRT1-dependent activities, and expression of one of these motifs in mice is sufficient to lower fasting glucose levels and improve glucose tolerance in a manner similar to overexpression of SIRT1. Our results provide insights into the regulation of SIRT1 activity and a rationale for pharmacological control of SIRT1-dependent activities.
引用
收藏
页码:1665 / 1673
页数:9
相关论文
共 50 条
  • [21] SIRT1 MAINTAINS ACTIN CYTOSKELETON BY DEACETYLATION OF CORTACTIN IN PODOCYTES
    Shuta, Motonishi
    Masaomi, Nangaku
    Takehiko, Wada
    Yu, Ishimoto
    Taiji, Matsusaka
    Akira, Shimizu
    Reiko, Inagi
    NEPHROLOGY, 2014, 19 : 48 - 48
  • [22] SIRT1 MAINTAINS ACTIN CYTOSKELETON BY DEACETYLATION OF CORTACTIN IN PODOCYTES
    Inagi, Reiko
    Motonishi, Shuta
    Nangaku, Masaomi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 45 - 45
  • [23] SIRT1 regulates HIV transcription via Tat deacetylation
    Pagans, S
    Pedal, A
    North, BJ
    Kaehlcke, K
    Marshall, BL
    Dorr, A
    Hetzer-Egger, C
    Henklein, P
    Frye, R
    McBurney, MW
    Hruby, H
    Jung, M
    Verdin, E
    Ott, M
    PLOS BIOLOGY, 2005, 3 (02) : 210 - 220
  • [24] SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis
    Zainabadi, Kayvan
    Liu, Cassie J.
    Caldwell, Alison L. M.
    Guarente, Leonard
    PLOS ONE, 2017, 12 (09):
  • [25] SRT2104, A NOVEL AND SELECTIVE SMALL MOLECULE SIRT1 ACTIVATOR, INHIBITS DSS-INDUCED COLITIS IN A SIRT1-DEPENDENT MANNER
    Ellis, J. L.
    Gagne, D. J.
    Suri, V.
    Cermak, J. M.
    Lyng, G. D.
    Guarente, L. P.
    Vlasuk, G. P.
    INFLAMMATION RESEARCH, 2011, 60 : 240 - 241
  • [26] A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo
    Leonardo Santos
    Laura Colman
    Paola Contreras
    Claudia C. Chini
    Adriana Carlomagno
    Alejandro Leyva
    Mariana Bresque
    Inés Marmisolle
    Celia Quijano
    Rosario Durán
    Florencia Irigoín
    Victoria Prieto-Echagüe
    Mikkel H. Vendelbo
    José R. Sotelo-Silveira
    Eduardo N. Chini
    Jose L. Badano
    Aldo J. Calliari
    Carlos Escande
    Scientific Reports, 9
  • [27] SirT1 and resveratrol regulates LKB1 localization by deacetylation and phosphorylation
    Ido, Yasuo
    Lan, Fan
    Cacicedo, Jose
    DIABETES, 2008, 57 : A411 - A411
  • [28] A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo
    Santos, Leonardo
    Colman, Laura
    Contreras, Paola
    Chini, Claudia C.
    Carlomagno, Adriana
    Leyva, Alejandro
    Bresque, Mariana
    Marmisolle, Ines
    Quijano, Celia
    Duran, Rosario
    Irigoin, Florencia
    Prieto-Echague, Victoria
    Vendelbo, Mikkel H.
    Sotelo-Silveira, Jose R.
    Chini, Eduardo N.
    Badano, Jose L.
    Calliari, Aldo J.
    Escande, Carlos
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] The differing effects of a dual acting regulator on SIRT1
    Hur, Yujin
    Huynh, Johnson
    Leong, Emily
    Dosanjh, Reena
    Charvat, Annemarie F.
    Vu, My H.
    Alam, Zain
    Lee, Yue Tong
    Cabreros, Christiane C.
    Carroll, Emma C.
    Hura, Greg L.
    Wang, Ningkun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [30] BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression
    Senawong, T
    Peterson, VJ
    Leid, M
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 434 (02) : 316 - 325